drugset / Trial / NCT06400589
A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of this study are to compare the efficacy and safety of tanfanercept ophthalmic solution 0.25% and 1.0% to vehicle for the treatment of DED.
Timeline
- Start
- 2024-05-01
- Primary completion
- 2025-08
- Completion
- 2025-08
Outcome
Outcome not reported
Stopped: “Logistical issue”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tanfanercept | Protein / enzyme biologic | 0.25 % | Other |
| Subject | tanfanercept | Protein / enzyme biologic | 1 % | Other |